Manufacturer price commitments as of April 2017 for pentavalent, pneumococcal, rotavirus, and HPV.
As part of the MICs Approach, Gavi offers a suite of catalytic tools to help drive the sustainable and equitable introduction of PCV, rotavirus, and HPV vaccines in both former and never Gavi-eligible countries, by addressing relevant barriers, including pricing. This support includes: technical assistance focused on addressing country-specific needs through Gavi’s in-country partners, as … Read More